Financials

  • Market Capitalization 40.67 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.39
ratio cours/chiffre d'affaires
—

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
218
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
746.54 USD+0.94%+1.66%-5.38%+35.24%76.86 B USD
309
ARGX
argenx SE - American Depositary Shares
825.03 USD+0.78%-10.34%-17.87%+3.55%51.06 B USD
434
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
232.68 USD+3.63%+6.56%-6.99%-48.99%31.13 B USD
496
ROIV
Roivant Sciences Ltd. - Common Shares
35.44 USD+3.60%-1.50%-12.80%+93.56%25.60 B USD

Nouvelles